Prostate cancer patients who also have long-term diabetes mellitus and/or diabetes with organ failure may have a higher likelihood of developing more aggressive, poorly differentiated disease….
Read More »Low Melatonin Doubles Diabetes Risk
The evidence for a link between the body clock hormone melatonin and type 2 diabetes continues to mount….
Read More »New Markers Predict When Diabetic Patients Develop Cognitive Decline
Stroke and subclinical markers of vascular disease may help predict which older patients with type 2 diabetes will develop cognitive decline….
Read More »Low Calorie Diet Similar to Bariatric Surgery
In patients with type 2 diabetes, insulin sensitivity and beta-cell function improved similarly with a very-low-calorie diet compared to bariatric surgery….
Read More »Pregnancy Complications Signal Diabetes’ Risk
Two more common conditions in pregnancy double the odds of being diagnosed with diabetes years later….
Read More »Cells That Increase Fat Burning Found in Humans
The find is crucial for fat research and future treatment of obesity….
Read More »Challenges in Identifying Postprandial Hypoglycemia, Part 2 of 4
With this week’s Homerun Slides series, we present the second set of a four part series which we’ll be bringing you over the course of four months. With this second set, we examine the currently available Postprandial Hyperglycemia Assessment Tools, and then explore one of the most recently discovered …
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #1: Diagnosing Diabetes
Anne Peters, MD, and Lori Laffel, MD, MPH, editors Jane Lee Chiang, MD, managing editor Diagnosing Diabetes Michael J. Haller, MD Standards of care endorsed by the American Diabetes Association (ADA) and the World Health Organization (WHO) provide a number of overlapping criteria for the diagnosis of diabetes. Based …
Read More »Pre-Exercise Evaluation and Assessment
By Sheri Colberg, PhD A safe and effective exercise program for people with diabetes minimizes the acute risks and long-term complications associated with physical activity while maximizing the benefits. As the benefits frequently outweigh the risks, regular participation in a variety of physical activities should be recommended and encouraged for …
Read More »Merck and Pfizer Collaborate to Develop New SGLT2 Drug, Ertugliflozin
There is currently fierce competition to get SGLT2 medications approved and onto the market. The first SGLT2 drug, Invokana (canagliflozin), developed by Johnson and Johnson, was approved by the FDA just recently. Ertugliflozin, which is ready for Phase III trials, will likely be marketed as a drug taken on its …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.